| Eargo is a medical device company. Co. is engaged in improving the quality of life of people with hearing loss. Co.'s in-the-canal devices feature high-quality audio, are designed to provide up to 16 hours of battery life and feature Co.'s proprietary soft and flexible medical-grade silicon tips. These silicon tips are removable, allowing for simple cleaning, and can be purchased separately in several sizes to accommodate individuals with different size ear canals. Co.'s rechargeable hearing aids are designed for ease of use and maintenance while providing a comfortable fit for a majority of its target market. The EAR average annual return since 2020 is shown above.
The Average Annual Return on the EAR average annual return since 2020 page and across the coverage universe of our site,
is a measure of the annualized return over the past ten years (or specified start date) for a given investment
(up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement
period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window
to capture long-term trends.
Thus, researching Average Annual Returns is good practice for investors — whether EAR average annual return since 2020 or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the EAR average annual return calculation with any dividends reinvested as applicable (on ex-dates).